Suppr超能文献

维持性血液透析患者的疼痛管理评估。

Pain Management Evaluation in Maintenance Hemodialysis Patients.

机构信息

Division of Health in the Community, Pain and Palliative Care Unit, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Soroka University Medical Center, Beer Sheva, Israel.

出版信息

Pain Med. 2021 Sep 8;22(9):1946-1953. doi: 10.1093/pm/pnaa488.

Abstract

CONTEXT

Pain is a common complaint in maintenance hemodialysis (MHD) patients, and it is often inadequately assessed and inappropriately treated.

OBJECTIVES

The study goal was to preliminarily evaluate pain management in MHD patients.

METHODS

The study was a cross-sectional study conducted in 2013-2015. A sample of 277 MHD patients who reported pain within the last 24 hours from five hospital hemodialysis units in Israel were interviewed and evaluated. Study tools included the Brief Pain Inventory, the Pain Management Index (PMI), demographic and clinical characteristics. Pharmacy computerized data were reviewed to identify the type of analgesics used.

RESULTS

Mean pain level was 7.2 ± 2.2 (median: 8). Pain level was mild in 17 (6.1%), moderate in 120 (43.3%) and severe in 140 (50.5%) of patients. Only 185 participants (66.8%) were treated with analgesics during the year prior to the interview. Of these, 99 (53.5%) received opioids. Using the PMI to preliminarily assess the appropriateness of the treatment, 214 (77.3%) of patients with pain in the last 24 hours were undertreated, and 52 patients (18.8%) were appropriately treated. In a multivariable analysis, factors associated with inappropriate treatment were severe pain intensity and a higher Functional Independent Measure (FIM). A lower FIM was associated with opioid use in a multivariable analysis.

CONCLUSIONS

According to the PMI, most dialysis patients were found to be inappropriately treated. About one third received opioids, but even among them, inappropriate treatment was common. Pain management in MHD patients needs to be improved.

摘要

背景

疼痛是维持性血液透析(MHD)患者常见的主诉,但往往评估不足且治疗不当。

目的

本研究旨在初步评估 MHD 患者的疼痛管理情况。

方法

本研究为 2013-2015 年的一项横断面研究。从以色列 5 家医院血液透析中心招募了 277 名在过去 24 小时内报告有疼痛的 MHD 患者进行访谈和评估。研究工具包括简短疼痛量表(BPI)、疼痛管理指数(PMI)、人口统计学和临床特征。回顾药房计算机化数据以确定使用的镇痛药类型。

结果

平均疼痛水平为 7.2±2.2(中位数:8)。17 名(6.1%)患者疼痛程度为轻度,120 名(43.3%)为中度,140 名(50.5%)为重度。在接受访谈前的 1 年内,仅有 185 名参与者(66.8%)接受了镇痛治疗。其中,99 名(53.5%)接受了阿片类药物治疗。使用 PMI 初步评估治疗的适当性,在过去 24 小时内有疼痛的 214 名(77.3%)患者治疗不足,52 名(18.8%)患者治疗适当。多变量分析显示,疼痛程度严重和功能独立性评分(FIM)较高与治疗不当相关。多变量分析显示,FIM 较低与使用阿片类药物相关。

结论

根据 PMI,大多数透析患者的治疗被认为是不适当的。约有三分之一的患者接受了阿片类药物治疗,但即使在这些患者中,治疗不当也很常见。需要改善 MHD 患者的疼痛管理。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验